Angiomyolipoma have common mutations in TSC2 but no other common genetic events

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Qin, Wei ^a   Bajaj, Vineeta ^a   Malinowska, Izabela ^a   Lu, Xin ^b   MacConaill, Laura ^c   Wu, Chin Lee ^b   Kwiatkowski, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RHEB PROTEIN; TUBERIN; MESSENGER RNA; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE; RHEB PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COPY NUMBER VARIATION; DNA SEQUENCE; FEMALE; FROZEN SECTION; GENE AMPLIFICATION; GENE DELETION; GENE FUSION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY HEMANGIOMYOLIPOMA; MALE; MASS SPECTROMETRY; MICROSATELLITE MARKER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUBEROUS SCLEROSIS; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE; CLINICAL TRIAL; ENZYME IMMUNOASSAY; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADULT; AGED; ANGIOMYOLIPOMA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; MUTATION; NEUROPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 80052825235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024919     Document Type: Article

References (25)

1. Fletcher C, Unni K, Mertens F, (2002) Pathology and Genetics of Tumours of Soft Tissue and Bone Lyon, France IARC.
2. Folpe AL, Kwiatkowski DJ, (2009) Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol 41: 1-15.
3. Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y, (1995) Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol 27: 124-127.
4. Bissler JJ, Kingswood JC, (2004) Renal angiomyolipomata. Kidney Int 66: 924-934.
5. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES, (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160: 141-145.
6. Siroky BJ, Czyzyk-Krzeska MF, Bissler JJ, (2009) Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms? Nat Clin Pract Nephrol 5: 143-156.
7. Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, et al. (2010) Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 105: 101-106.
8. Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, et al. (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358: 140-151.
9. Halpenny D, Snow A, McNeill G, Torreggiani WC, (2010) The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol 65: 99-108.
10. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F, (2008) PEComas: the past, the present and the future. Virchows Arch 452: 119-132.
11. Lim SD, Stallcup W, Lefkove B, Govindarajan B, Au KS, et al. (2007) Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Mol Med 13: 160-165.
12. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, et al. (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59: 400-406.
13. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, et al. (1995) Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes, Chromosomes & Cancer 13: 295-298.
14. Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, et al. (1998) Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 62: 810-815.
15. Carsillo T, Astrinidis A, Henske EP, (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 97: 6085-6090.
16. Robb VA, Astrinidis A, Henske EP, (2006) Frequent hyperphosphorylation of ribosomal protein S6 in lymphangioleiomyomatosis-associated angiomyolipomas. Mod Pathol 19: 839-846.
17. Pan CC, Chung MY, Ng KF, Liu CY, Wang JS, et al. (2008) Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol 214: 387-393.
18. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ, (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361: 1348-1349.
19. Kenerson H, Folpe AL, Takayama TK, Yeung RS, (2007) Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol 38: 1361-1371.
20. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, et al. (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116: 1919-1923.
21. Kwiatkowski DJ, Thiele EA, Whittemore VH, (2010) Tuberous sclerosis complex Weinheim, Germany Wiley-VCH.
22. Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, et al. (2007) Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 121: 389-400.
23. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, et al. (2011) Integrative genomics viewer. Nat Biotechnol 29: 24-26.
24. Kwiatkowski DJ, Manning BD, (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. pp. R251-8 Hum Mol Genet 14 Spec No. 2.
25. Zoncu R, Efeyan A, Sabatini DM, (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.